Evaluation of Digoxin for Relapsed non-WNT, non-SHH Medulloblastoma (Phase 2 Study)

Disease Sites:

Neuro-Oncology, Pediatrics

Staging:

Phase II

Age Group:

Both

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Esbenshade, Adam

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

10-16-2025

Trial Type:

Treatment

Protocol ID:

VICCPED24621

National Clinical Trial ID:

NCT06701812

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available